Antimicrobial activity of isepamicin (SCH21420, 1-N-HAPA gentamicin B) combinations with cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, imipenem, mezlocillin and piperacillin tested against gentamicin-resistant and susceptible gram-negative bacilli and enterococci.

Jones, R N

Antimicrobial activity of isepamicin (SCH21420, 1-N-HAPA gentamicin B) combinations with cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, imipenem, mezlocillin and piperacillin tested against gentamicin-resistant and susceptible gram-negative bacilli and enterococci. [electronic resource] - Journal of chemotherapy (Florence, Italy) Oct 1991 - 289-94 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1120-009X

10.1080/1120009x.1991.11739108 doi


Cefotaxime--pharmacology
Ceftazidime--pharmacology
Culture Media
Drug Interactions
Drug Resistance, Microbial
Drug Synergism
Drug Therapy, Combination--pharmacology
Enterobacteriaceae--drug effects
Enterococcus--drug effects
Gentamicins--pharmacology
Gram-Negative Bacteria--drug effects
Imipenem--pharmacology
Mezlocillin--pharmacology
Piperacillin--pharmacology
Pseudomonas--drug effects